WO2014038878A3 - 머스크랫의 사향을 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물 - Google Patents

머스크랫의 사향을 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물 Download PDF

Info

Publication number
WO2014038878A3
WO2014038878A3 PCT/KR2013/008045 KR2013008045W WO2014038878A3 WO 2014038878 A3 WO2014038878 A3 WO 2014038878A3 KR 2013008045 W KR2013008045 W KR 2013008045W WO 2014038878 A3 WO2014038878 A3 WO 2014038878A3
Authority
WO
WIPO (PCT)
Prior art keywords
brain
treatment
composition
alleviation
disease prevention
Prior art date
Application number
PCT/KR2013/008045
Other languages
English (en)
French (fr)
Other versions
WO2014038878A2 (ko
Inventor
류보렬
Original Assignee
Ryu Bouryeol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ryu Bouryeol filed Critical Ryu Bouryeol
Priority to CN201380046906.0A priority Critical patent/CN104619331A/zh
Priority to US14/426,759 priority patent/US20150238539A1/en
Publication of WO2014038878A2 publication Critical patent/WO2014038878A2/ko
Publication of WO2014038878A3 publication Critical patent/WO2014038878A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Insects & Arthropods (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)

Abstract

본 발명은 서사향을 유효성분으로 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물에 관한 것으로, 상기 조성물은 신경재생 개선, 신경세포의 손상억제, 알쯔하이머 치매의 예방 및 치료에 탁월한 약리효과를 가진다.
PCT/KR2013/008045 2012-09-07 2013-09-06 머스크랫의 사향을 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물 WO2014038878A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201380046906.0A CN104619331A (zh) 2012-09-07 2013-09-06 保护脑神经细胞及预防、缓和或治疗脑部疾病的含有麝鼠香的组合物
US14/426,759 US20150238539A1 (en) 2012-09-07 2013-09-06 Composition for brain-neuron protection and brain-disease prevention, alleviation or treatment comprising muskrat musk

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120099541A KR101476750B1 (ko) 2012-09-07 2012-09-07 머스크랫의 사향을 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물
KR10-2012-0099541 2012-09-07

Publications (2)

Publication Number Publication Date
WO2014038878A2 WO2014038878A2 (ko) 2014-03-13
WO2014038878A3 true WO2014038878A3 (ko) 2014-05-08

Family

ID=50237728

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/008045 WO2014038878A2 (ko) 2012-09-07 2013-09-06 머스크랫의 사향을 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물

Country Status (4)

Country Link
US (1) US20150238539A1 (ko)
KR (1) KR101476750B1 (ko)
CN (1) CN104619331A (ko)
WO (1) WO2014038878A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102317197B1 (ko) * 2019-11-27 2021-10-25 주식회사 한웅 서사향의 항비만 활성을 이용한 건강기능식품 조성물 및 그의 제조방법
CN111991423A (zh) * 2020-09-30 2020-11-27 中国农业科学院特产研究所 一种鹿茸醇提取物的制备方法及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100259176B1 (ko) * 1997-05-21 2000-06-15 Choseon Pharm & Trading Co Ltd 엘-무스콘의 의약용도
US20050233004A1 (en) * 2004-04-20 2005-10-20 Yeong-Ok Kim Composition of Chinese drugs having neuro-protecting activity
KR20100133655A (ko) * 2009-06-12 2010-12-22 박철기 삼칠 추출물을 유효성분으로 하는 뇌졸중과 치매를 포함하는 퇴행성 뇌질환의 예방 및 치료용 약제학적 조성물 및 기능성식품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050118749A (ko) * 2004-06-15 2005-12-20 박미선 나노입자 금분을 함유하는 공진단
WO2008075862A1 (en) * 2006-12-16 2008-06-26 Pusan National University Industry-University Cooperation Foundation A method for preparing materials having antithrombotic activity from muskrat musk and materials obtained from the method
KR20120038611A (ko) * 2010-10-14 2012-04-24 주식회사한국전통의학연구소 생약 추출물을 포함하는 간암 예방 또는 치료용 약학적 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100259176B1 (ko) * 1997-05-21 2000-06-15 Choseon Pharm & Trading Co Ltd 엘-무스콘의 의약용도
US20050233004A1 (en) * 2004-04-20 2005-10-20 Yeong-Ok Kim Composition of Chinese drugs having neuro-protecting activity
KR20100133655A (ko) * 2009-06-12 2010-12-22 박철기 삼칠 추출물을 유효성분으로 하는 뇌졸중과 치매를 포함하는 퇴행성 뇌질환의 예방 및 치료용 약제학적 조성물 및 기능성식품

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HYOCHANG JUNG ET AL.: "A study of Gongjin-dan in patients with mild Dementia of Alzheimer type", JOURNAL OF ORIENTAL NEUROPSYCHIATRY, vol. 15, no. 2, 2004, pages 141 - 148 *
SEON-MI HWANG ET AL.: "The effect of KongJin-Dan(KJD) on the Alzheimer's Disease Model Induced by CT105", JOURNAL OF ORIENTAL NEUROPSYCHIATRY, vol. 15, no. 2, 2004, pages 103 - 118 *
THE MINISTRY OF AGRICULTURE, FOOD AND RURAL AFFAIRS: "Development of the technology for culturing and processing of muskrat", FINAL RESEARCH REPORT, 2011 *

Also Published As

Publication number Publication date
CN104619331A (zh) 2015-05-13
KR20140032805A (ko) 2014-03-17
US20150238539A1 (en) 2015-08-27
WO2014038878A2 (ko) 2014-03-13
KR101476750B1 (ko) 2014-12-26

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
WO2016064082A3 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
CA2865011C (en) Methods and compositions for treating huntington's disease
CA2900779C (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
WO2013142124A8 (en) Solid forms of a thiophosphoramidate nucleotide prodrug
WO2012042404A3 (en) Antimicrobial, antibacterial and spore germination inhibiting activity from an avocado extract enriched in bioactive compounds
EP2941263A4 (en) PURIFIED EXTRACT ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR SUBINTEGRUM CONTAINING A LARGE QUANTITY OF ACTIVE INGREDIENT, PREPARATION THEREOF AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT TO PREVENT INFLAMMATION, ALLERGY AND ASTHMA
JOP20130313B1 (ar) عامل وقائي و/أو علاجي للأعراض السلوكية والنفسية المصحوبة بمرض تنكسي عصبي أو الأعراض الإندفاعية المصحوبة بمرض ذهني، يحتوي على بريكسبيرازول أو ملحه
WO2011107462A3 (de) Sonnenschutz-zusammensetzungen
WO2013098416A3 (fr) Composes anti-douleur
MX2014010563A (es) Benzodioxanos en combinacion con otros activos para inhibir la produccion de leucotrieno.
WO2014114888A3 (fr) Système de protection alternatif contre les uv et radicaux libres
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
WO2013102882A3 (en) Cosmetic use of dedifferentiated plant cells
PH12017500615B1 (en) Ophthalmic composition comprising cyclosporine and trehalose
WO2014043230A3 (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
WO2013034855A3 (fr) Association de carraghénane et de c-glycoside et leurs utilisations
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
WO2014004934A3 (en) Compositions and methods of treating alzheimer's disease
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
CL2014003607A1 (es) Compuestos derivados de benzodioxol, inhibidores de la acetilcolinesterasa; metodo de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o el tratamiento de la enfermedad de alzheimer.
WO2016108572A3 (ko) 콜레스테롤 관련 질환의 예방 및 치료용 조성물
WO2014038878A3 (ko) 머스크랫의 사향을 함유하는 뇌신경세포 보호 및 뇌질환 예방, 완화 또는 치료용 조성물
WO2014124398A3 (en) Assemblies for personal restraint

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13835026

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14426759

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 13835026

Country of ref document: EP

Kind code of ref document: A2